Bgm (BGM) Operating Leases (2020 - 2025)

Bgm's (BGM) quarterly Operating Leases came in at $79311.0 in Q3 2025, down 71.47% year-on-year from $278012.0 in Q3 2024, and down 22.1% on a QoQ basis from $101814.0 in Q1 2025.

Bgm (BGM) Operating Leases (2020 - 2025) Analysis & Trends

Bgm (BGM) has 6 years of Operating Leases data on file, last reported at $79311.0 in Q3 2025.

  • On a quarterly basis, Operating Leases fell 71.47% year-over-year to $79311.0 in Q3 2025; TTM through Sep 2025 was $79311.0, a 71.47% decrease from a year earlier, with the FY2025 full-year figure at $79311.0, down 71.47% from the prior year.
  • Operating Leases for Q3 2025 stood at $79311.0, down from $101814.0 in the prior quarter.
  • Over the last five years, Operating Leases for BGM reached as high as $79.1 billion in Q1 2022 and fell as low as $24575.0 in Q3 2023.
  • Historically, Operating Leases has averaged $15.9 billion across 5 years, with a median of $103997.0 in 2021.
  • Across the five-year window, Operating Leases jumped 1031.28% in 2024 and tumbled 71.47% in 2025, its largest moves.
  • Year by year, Operating Leases stood at $106180.0 in 2021, then sank by 31.68% to $72537.0 in 2022, then tumbled by 66.12% to $24575.0 in 2023, then soared by 1031.28% to $278012.0 in 2024, then plunged by 71.47% to $79311.0 in 2025.
  • Per Business Quant data, the three most recent Operating Leases figures were $79311.0 in Q3 2025, $101814.0 in Q1 2025, and $278012.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Bgm 33.55 Mn 23.73 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 79,311.00
Mar 31, 2025 101,814.00
Sep 30, 2024 278,012.00
Sep 30, 2023 24,575.00
Mar 31, 2023 47.70 Bn
Sep 30, 2022 72,537.00
Mar 31, 2022 79.15 Bn
Sep 30, 2021 106,180.00
Sep 30, 2020 155,723.00